Proposed infant apnea monitor standard based on bench testing is released by FDA.
This article was originally published in The Gray Sheet
Executive Summary
INFANT APNEA MONITOR STANDARD BASED ON BENCH TESTING rather than clinical trials is proposed by FDA in a Feb. 21 Federal Register notice. The revised version of the standard was expected to include clinical testing requirements, but FDA says that performance of apnea monitors currently on the market can be demonstrated without clinical trials. Comments on the proposal are due by May 22.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.